Shares of Health Care sector company Integra LifeSciences moved -4.6% today, and are now trading at a price of $35.5. The mid-cap stock's daily volume was 219,788 compared to its average volume of 647,596. The S&P 500 index returned a -1.0% performance.
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. The company is based in Princeton and has 3,722 full time employees. Its market capitalization is $2,889,835,008.
9 analysts are following Integra LifeSciences and have set target prices ranging from $36.0 to $60.0 per share. On average, they have given the company a rating of hold. At today's prices, IART is trading -24.29% away from its average analyst target price of $46.89 per share.
Over the last year, IART shares have gone down by -25.0%, which represents a difference of -36.0% when compared to the S&P 500. The stock's 52 week high is $60.69 per share and its 52 week low is $33.44. With average free cash flows of $181.76 Million that have been growing at an average rate of 4.1% over the last 6 years, Integra LifeSciences declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 208,082 | 52,863 | 155,219 | -30.12 |
| 2022 | 264,469 | 42,343 | 222,126 | -15.99 |
| 2021 | 312,427 | 48,022 | 264,405 | 60.3 |
| 2020 | 203,832 | 38,890 | 164,942 | 1.88 |
| 2019 | 231,433 | 69,537 | 161,896 | 32.76 |
| 2018 | 199,683 | 77,741 | 121,942 |
